We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To...
Topline results from pivotal Phase 3 study of uproleselan in relapsed/refractory (R/R) Acute Myeloid Leukemia (AML) to be reported in Q2 2024 New Drug Application (NDA) for uproleselan to be...
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report fourth quarter and 2023 full year financial results on Wednesday, March 27, 2024 at...
GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Harout Semerjian, Chief Executive Officer, will participate in the Leukemia Panel at the Cowen 44th Annual Health Care Conference in...
GlycoMimetics, Inc. (the βCompanyβ) (NASDAQ:GLYC) today announced that the Compensation Committee of the Companyβs Board of Directors approved the grant on February 6, 2024 of a non-qualified...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.58 | -25.327510917 | 2.29 | 2.3577 | 1.695 | 1081992 | 1.89993264 | CS |
4 | -1.36 | -44.2996742671 | 3.07 | 3.16 | 1.695 | 746378 | 2.32400965 | CS |
12 | -1.32 | -43.5643564356 | 3.03 | 3.38 | 1.695 | 455492 | 2.61928441 | CS |
26 | 0.56 | 48.6956521739 | 1.15 | 3.5299 | 1.11 | 348055 | 2.57056753 | CS |
52 | 0.3 | 21.2765957447 | 1.41 | 3.5299 | 1.11 | 262950 | 2.26943166 | CS |
156 | -0.83 | -32.6771653543 | 2.54 | 4.16 | 0.51 | 434893 | 2.10415072 | CS |
260 | -11.05 | -86.5987460815 | 12.76 | 13.41 | 0.51 | 484224 | 3.04731154 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions